Microbix Biosystems Stock Performance
| MBX Stock | CAD 0.43 0.02 4.88% |
Microbix Biosystems has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.09, which conveys a somewhat significant risk relative to the market. Microbix Biosystems returns are very sensitive to returns on the market. As the market goes up or down, Microbix Biosystems is expected to follow. Microbix Biosystems right now secures a risk of 4.33%. Please verify Microbix Biosystems downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Microbix Biosystems will be following its current price movements.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Microbix Biosystems are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Microbix Biosystems may actually be approaching a critical reversion point that can send shares even higher in May 2025. ...more
| Begin Period Cash Flow | 11.6 M |
Microbix |
Microbix Biosystems Relative Risk vs. Return Landscape
If you would invest 41.00 in Microbix Biosystems on January 1, 2025 and sell it today you would earn a total of 2.00 from holding Microbix Biosystems or generate 4.88% return on investment over 90 days. Microbix Biosystems is generating 0.1658% of daily returns assuming 4.3293% volatility of returns over the 90 days investment horizon. Simply put, 38% of all stocks have less volatile historical return distribution than Microbix Biosystems, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Microbix Biosystems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbix Biosystems' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Microbix Biosystems, and traders can use it to determine the average amount a Microbix Biosystems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0383
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MBX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Microbix Biosystems is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Microbix Biosystems by adding it to a well-diversified portfolio.
Microbix Biosystems Fundamentals Growth
Microbix Stock prices reflect investors' perceptions of the future prospects and financial health of Microbix Biosystems, and Microbix Biosystems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microbix Stock performance.
| Return On Equity | 0.0685 | ||||
| Return On Asset | 0.0379 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 51.47 M | ||||
| Shares Outstanding | 141.64 M | ||||
| Price To Book | 2.01 X | ||||
| Price To Sales | 2.52 X | ||||
| Revenue | 25.39 M | ||||
| EBITDA | 3.58 M | ||||
| Cash And Equivalents | 402.12 K | ||||
| Total Debt | 111.12 K | ||||
| Debt To Equity | 0.53 % | ||||
| Book Value Per Share | 0.21 X | ||||
| Cash Flow From Operations | 4.35 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Total Asset | 38.1 M | ||||
| Retained Earnings | (33.39 M) | ||||
About Microbix Biosystems Performance
By examining Microbix Biosystems' fundamental ratios, stakeholders can obtain critical insights into Microbix Biosystems' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Microbix Biosystems is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.Things to note about Microbix Biosystems performance evaluation
Checking the ongoing alerts about Microbix Biosystems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microbix Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| Microbix Biosystems had very high historical volatility over the last 90 days | |
| About 14.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Microbix Biosystems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microbix Biosystems' stock is overvalued or undervalued compared to its peers.
- Examining Microbix Biosystems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microbix Biosystems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microbix Biosystems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Microbix Biosystems' stock. These opinions can provide insight into Microbix Biosystems' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.